Dr. Gregory S. Wang, MD

Dr. Wang practices at Bull Run Dialysis in Manassas, Virginia.

Dr. Wang's NPI, 1871778068, was assigned on January 7, 2008. Dr. Wang graduated from University of Maryland School of Medicine in 2003. Dr. Wang holds Virginia license 0101242854.

Dr. Wang's primary practice is Bull Run Dialysis, at 9378 Forestwood Ln, Manassas, VA 20110 in Manassas City. The practice phone is (703) 257-1749.

Dr. Wang's primary practice is Bull Run Dialysis in Manassas, Virginia. Dr. Wang is also affiliated with Inova Fairfax Hospital. The medical group on file is Nephrology Associates of Northern Virginia (NANV). Dmand AI also links Dr. Wang to 4 more hospitals, 5 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Wang is licensed in Virginia.

CMS data shows 2,703 Medicare services from Dr. Wang across 13 procedure codes in 2024, for 797 Medicare patients. Medicare paid $204,657 for them.

CMS counts 797 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 327 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 69, with 42% women.

In 2024, Dr. Wang wrote 1,689 Medicare Part D claims for 253 patients. 91% of them were for generic drugs. CMS names the drug for 1,367 of them, across 42 drugs with 11 or more claims each, at $111,508 in total drug cost. In 2023, CMS named 1,057 claims across 35 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Wang, published from 2021 to 2024. 2022 was the busiest year, with 5. The most frequent topics are COVID-19, SARS-CoV-2 and Antibodies, Viral. Dr. Wang has published most often in Front Immunol. Dr. Wang's most frequent co-authors are Edward E. Mitre, MD, David Ray Tribble, MD and Timothy H. Burgess, MD, MPH.

CMS Open Payments shows 106 general payments to Dr. Wang from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,341.

Dr. Wang graduated from University of Maryland School of Medicine in 2003.